Tiger Brokers

iX Biopharma issues 250,000 new shares after warrant exercises

SGX Filings
May 15

iX Biopharma Ltd. announced on May, 15 2026 that it has allotted and issued 250,000 new ordinary shares following the exercise of warrants at an exercise price of 0.06 Singapore dollars per share. The company’s total issued share capital has risen to 1,056,907,215 shares from 1,056,657,215 shares.

The newly issued shares rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange Securities Trading Limited on or around May, 19 2026.

Cumulatively, 20,730,151 warrants—representing 36.05% of all warrants previously issued—have been exercised to date. A total of 36,779,328 warrants remain outstanding, each carrying an exercise price of 0.06 Singapore dollars and expiring on Jul, 18 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10